{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:50:44Z","timestamp":1760921444757,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.semcancer.2020.10.004","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T13:29:28Z","timestamp":1603114168000},"page":"132-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["NanoString in the screening of genetic abnormalities associated with thyroid cancer"],"prefix":"10.1016","volume":"79","author":[{"given":"Elisabetta","family":"Macerola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-8249","authenticated-orcid":false,"given":"Anello Marcello","family":"Poma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1657-5020","authenticated-orcid":false,"given":"Fulvio","family":"Basolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2016","key":"10.1016\/j.semcancer.2020.10.004_bib0005","first-page":"1","article-title":"American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2015","journal-title":"Thyroid."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0010","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1309\/AJCPPHLWMI3JV4LA","article-title":"NCI thyroid FNA state of the science conference, the bethesda system for reporting thyroid cytopathology","volume":"132","author":"Cibas","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40618-014-0062-0","article-title":"Italian consensus for the classification and reporting of thyroid cytology","volume":"37","author":"Nardi","year":"2014","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817729231","article-title":"Evaluation and management of indeterminate thyroid nodules: the revolution of risk stratification beyond cytological diagnosis","volume":"24","author":"Valderrabano","year":"2017","journal-title":"Cancer Control"},{"key":"10.1016\/j.semcancer.2020.10.004_bib0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/14737159.2017.1268533","article-title":"NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics","volume":"17","author":"Tsang","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0030","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/14737159.2019.1623672","article-title":"Application of NanoString technologies in companion diagnostic development","volume":"19","author":"Eastel","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0035","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0040","article-title":"A cross comparison of technologies for the detection of microRNAs in clinical FFPE samples of hepatoblastoma patients","volume":"5","author":"Chatterjee","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0045","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-15-0262","article-title":"Evaluating robustness and sensitivity of the NanoString technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples","volume":"75","author":"Veldman-Jones","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12920-015-0129-6","article-title":"Development and verification of the PAM50-based Prosigna breast cancer gene signature assay","volume":"8","author":"Wallden","year":"2015","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.semcancer.2020.10.004_bib0055","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.7150\/jca.24744","article-title":"Gene expression detection assay for Cancer Clinical use","volume":"9","author":"Narrandes","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.semcancer.2020.10.004_bib0060","doi-asserted-by":"crossref","first-page":"10978","DOI":"10.18632\/oncotarget.3452","article-title":"Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysis","volume":"6","author":"Chitikova","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2020.10.004_bib0065","doi-asserted-by":"crossref","first-page":"45776","DOI":"10.18632\/oncotarget.10166","article-title":"Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma","volume":"7","author":"Makhlouf","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2020.10.004_bib0070","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1089\/thy.2016.0605","article-title":"Identification of two distinct molecular subtypes of non-invasive follicular neoplasm with papillary-like nuclear features by digital RNA counting","volume":"27","author":"Giannini","year":"2017","journal-title":"Thyroid."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/modpathol.2016.157","article-title":"miRNA expression profiling of \u201cnoninvasive follicular thyroid neoplasms with papillary-like nuclear features\u201d compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas","volume":"30","author":"Borrelli","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0080","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/ERC-17-0167","article-title":"Differences in miRNA expression profiles between wild-type and mutated NIFTPs","volume":"24","author":"Denaro","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2020.10.004_bib0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1530\/EC-17-0261","article-title":"A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma","volume":"7","author":"Poma","year":"2018","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cncy.21564","article-title":"Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules","volume":"123","author":"Giannini","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0095","article-title":"Digital gene expression analysis on cytology smears can rule-out malignancy in follicular-patterned thyroid tumors","author":"Macerola","year":"2019","journal-title":"J. Mol. Diagn. JMD."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0100","doi-asserted-by":"crossref","first-page":"E338","DOI":"10.1210\/jc.2013-2792","article-title":"RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma","volume":"99","author":"Smallridge","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0105","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-01167","article-title":"Immune profiling of thyroid carcinomas suggests the existence of two major phenotypes: an ATC-like and a PDTC-like","author":"Giannini","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0110","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.26639","article-title":"DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions","volume":"10","author":"Poma","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2020.10.004_bib0115","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.3892\/or.2016.5113","article-title":"Selection and validation of miRNAs as normalizers for profiling expression of microRNAs isolated from thyroid fine needle aspiration smears","volume":"36","author":"Titov","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0120","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1210\/jc.2019-00431","article-title":"Genomic and transcriptomic characterization of papillary microcarcinomas with lateral neck lymph node metastases","volume":"104","author":"Perera","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mce.2018.09.005","article-title":"mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases","volume":"479","author":"Condello","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/EJE-16-0252","article-title":"Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients","volume":"175","author":"Tiedje","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.5858\/arpa.2017-0135-RA","article-title":"Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?","volume":"142","author":"Al\u00ec","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/srep42259","article-title":"Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer","volume":"7","author":"Rogers","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/ERC-14-0467","article-title":"Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer","volume":"22","author":"Park","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2020.10.004_bib0150","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4143\/crt.2016.424","article-title":"Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer","volume":"49","author":"Lee","year":"2017","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2020.10.004_bib0155","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3390\/ijms18040806","article-title":"Diagnostic limitation of fine-needle aspiration (FNA) on indeterminate thyroid nodules can Be partially overcome by preoperative molecular analysis: assessment of RET\/PTC1 rearrangement in BRAF and RAS wild-type routine air-dried FNA specimens","volume":"18","author":"Ko","year":"2017","journal-title":"Int. J. Mol. Sci."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X20302091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X20302091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:55:09Z","timestamp":1760918109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X20302091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":31,"alternative-id":["S1044579X20302091"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.10.004","relation":{},"ISSN":["1044-579X"],"issn-type":[{"type":"print","value":"1044-579X"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NanoString in the screening of genetic abnormalities associated with thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}